Indalo Therapeutics
St Louis
About Indalo Therapeutics
Indalo Therapeutics is a preclinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating fibrotic diseases. Founded on groundbreaking scientific discoveries and leveraging cutting-edge insight into the molecular drivers of aberrant scarring, Indalo is harnessing the collective experience of a seasoned team of pharmaceutical scientists and executives to tackle some of the most urgent unmet medical needs in the fibrosis space.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.8M
- Last round: Series Unknown (Aug 2017)
- Website: indalotherapeutics.com
- Phone: +32 2 290 34 90
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/indalo-therapeutics-166084 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.